Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy

Detalhes bibliográficos
Autor(a) principal: Zelmanovitz, Themis
Data de Publicação: 2022
Outros Autores: L. Gross, Jorge, Oliveira, Jarbas, J. de Azevedo, Mirela
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/124652
Resumo: OBJECTIVE: To assess the performance of urinary total protein measurements intimed 24-h urine collection and in a diurnal random urine specimen for the screeningand diagnosis of overt diabetic nephropathy.PATIENTS AND METHODS: A total of 167 diabetic patients (20 type 1 and 147 type2 diabetic patients; 78 women and 89 men), aged 20-84 years, collected 217 timed24-h urine specimens. Albumin was measured by immunoturbidimetry, total proteinby the sulfosalicylic acid technique, and creatinine by Jaffé’s method. According tothe timed 24-h urinary albumin excretion rate, samples were divided into three groups:normoalbuminuric (urinary albumin excretion rate < 20 mg/min; n = 84),microalbuminuric (urinary albumin excretion rate 20-200 mg/min; n = 78), andmacroalbuminuric (urinary albumin excretion rate > 200 mg/min; n = 55). Eight-sixpatients also collected 105 random urine specimens (normoalbuminuric, n = 47;microalbuminuric, n = 37; macroalbuminuric, n = 21), and urinary protein concentrationand urinary protein-to-creatinine ratio were measured. The receiver operatingcharacteristics curve approach was used to analyze the performance of the diagnostictests.RESULTS: Spearman’s coefficient of correlation of 24-h urinary albumin excretionrate versus 24-h urinary protein was 0.95 ( P < 0.001), and of 24-h urinary albuminexcretion rate versus urinary protein concentration and urinary protein-to-creatinineratio were 0.77 and 0.72, respectively (P < 0.001). The calculated areas (±SEM)under the receiver operating characteristics curve for the diagnosis of overt diabeticnephropathy were 0.9987 ± 0.001 for 24-h urinary protein, 0.9926 ± 0.006 for urinaryprotein concentration, and 0.9751 ± 0.014 for urinary protein-to-creatinine ratio. Inthe receiver operating characteristics curves, the first points with 100% sensivitywere 541 mg (95.7% specificity) for 24-h urinary protein, 431 mg/l (92.9% specificity)for urinary protein concentration, and 0.2 (76.2% specificity) for urinary protein-tocreatinine ratio.CONCLUSIONS: Measurements of proteinuria presented almost perfect accuracyfor the screening and diagnosis of overt diabetic nephropathy. Protein measurementin spot urine is a reliable and simple method for the screening and diagnosis of overtdiabetic nephropathy.
id UFRGS-20_172aec7f9736b3afbb4c5db9348414f4
oai_identifier_str oai:seer.ufrgs.br:article/124652
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathyProteinúria ainda é útil para triagem e diagnóstico de nefropatia diabética sintomáticaOBJECTIVE: To assess the performance of urinary total protein measurements intimed 24-h urine collection and in a diurnal random urine specimen for the screeningand diagnosis of overt diabetic nephropathy.PATIENTS AND METHODS: A total of 167 diabetic patients (20 type 1 and 147 type2 diabetic patients; 78 women and 89 men), aged 20-84 years, collected 217 timed24-h urine specimens. Albumin was measured by immunoturbidimetry, total proteinby the sulfosalicylic acid technique, and creatinine by Jaffé’s method. According tothe timed 24-h urinary albumin excretion rate, samples were divided into three groups:normoalbuminuric (urinary albumin excretion rate < 20 mg/min; n = 84),microalbuminuric (urinary albumin excretion rate 20-200 mg/min; n = 78), andmacroalbuminuric (urinary albumin excretion rate > 200 mg/min; n = 55). Eight-sixpatients also collected 105 random urine specimens (normoalbuminuric, n = 47;microalbuminuric, n = 37; macroalbuminuric, n = 21), and urinary protein concentrationand urinary protein-to-creatinine ratio were measured. The receiver operatingcharacteristics curve approach was used to analyze the performance of the diagnostictests.RESULTS: Spearman’s coefficient of correlation of 24-h urinary albumin excretionrate versus 24-h urinary protein was 0.95 ( P < 0.001), and of 24-h urinary albuminexcretion rate versus urinary protein concentration and urinary protein-to-creatinineratio were 0.77 and 0.72, respectively (P < 0.001). The calculated areas (±SEM)under the receiver operating characteristics curve for the diagnosis of overt diabeticnephropathy were 0.9987 ± 0.001 for 24-h urinary protein, 0.9926 ± 0.006 for urinaryprotein concentration, and 0.9751 ± 0.014 for urinary protein-to-creatinine ratio. Inthe receiver operating characteristics curves, the first points with 100% sensivitywere 541 mg (95.7% specificity) for 24-h urinary protein, 431 mg/l (92.9% specificity)for urinary protein concentration, and 0.2 (76.2% specificity) for urinary protein-tocreatinine ratio.CONCLUSIONS: Measurements of proteinuria presented almost perfect accuracyfor the screening and diagnosis of overt diabetic nephropathy. Protein measurementin spot urine is a reliable and simple method for the screening and diagnosis of overtdiabetic nephropathy.OBJETIVO: Avaliar a utilização de medições de proteína urinária total em coletasurinárias de 24 horas e em amostras diurnas coletadas aleatoriamente para triageme diagnóstico de nefropatia diabética sintomática. PACIENTES E MÉTODOS: Foram coletadas 217 amostras de urina a cada 24 h deum total de 167 pacientes diabéticos (20 pacientes com diabetes tipo 1 e 147 comdiabetes tipo 2; 78 mulheres e 89 homens), com idade entre 20 e 84 anos. A albuminafoi medida por imunoturbidimetria, a proteína urinário total foi medida pela técnicado ácido sulfosalicílico e a creatinina, pelo método de Jaffe. As amostras foramdivididas em três grupos de acordo com a taxa de 24 h de excreção urinária dealbumina: normoalbuminúricos (taxa de excreção urinária de albumina < 20 mg/min;n=84), microalbuminúricos (taxa de excreção urinária de albumina 20-200 mg/min;n=78), e macroalbuminúricos (taxa de excreção urinária de albumina > 200 mg/min;n=55). Foram coletadas ainda 105 amostras aleatórias de urina de 86 pacientes(normoalbuminúricos, n=47; microalbuminúricos, n=37; macroalbuminúricos, n=21),das quais a concentração urinária de proteina e a relação proteína/creatinina urináriaforam obtidas. O método da curva de características operacionais do receptor foiutilizado para analisar o desempenho dos testes diagnósticos.RESULTADOS: O coeficiente de correlação de Spearman para a comparação entrea taxa de 24 h de excreção urinária de albumina e a proteina urinária de 24 h foi 0,95(P < 0,001). O mesmo coeficiente, para a comparação da taxa de 24 h de excreçãourinária de albumina com a concentração urinária de proteina, assim como com arelação proteína/creatinina urinária foi 0,77 e 0,72, respectivamente (P < 0,001). Asáreas calculadas (+ erro padrão) abaixo da curva de características operacionais doreceptor para o diagnóstico de nefropatia diabética sintomática foram: 0,9987 + 0,001para a proteina urinária de 24 h; 0,9926 + 0,006 para concentração urinária deproteína; e 0,9751 + 0,014 para a relação proteina/creatinina urinária. Nas curvasde características operacionais do receptor os primeiros pontos com 100% desensitividade foram: 541mg (95,7% de especificidade) para proteína urinária de 24h, 431 mg/l (92,9% de especificidade) para concentração urinária, e 0,2 (76,2% deespecificidade) para a relação proteína/creatinina urinária.CONCLUSÕES: As medidas de proteinuria foram extremamente eficazes na triageme no diagnóstico de nefropatia diabética sintomática. A medição de proteína urináriaé um método confiável e simples para a triagem e diagnóstico de nefropatia diabéticasintomáticaHCPA/FAMED/UFRGS2022-05-25info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionA Convite dos Editoresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/124652Clinical & Biomedical Research; Vol. 18 No. 2 (1998): Revista HCPAClinical and Biomedical Research; v. 18 n. 2 (1998): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/124652/84914http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessZelmanovitz, Themis L. Gross, Jorge Oliveira, JarbasJ. de Azevedo, Mirela 2022-09-16T16:32:21Zoai:seer.ufrgs.br:article/124652Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-09-16T16:32:21Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
Proteinúria ainda é útil para triagem e diagnóstico de nefropatia diabética sintomática
title Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
spellingShingle Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
Zelmanovitz, Themis
title_short Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
title_full Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
title_fullStr Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
title_full_unstemmed Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
title_sort Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy
author Zelmanovitz, Themis
author_facet Zelmanovitz, Themis
L. Gross, Jorge
Oliveira, Jarbas
J. de Azevedo, Mirela
author_role author
author2 L. Gross, Jorge
Oliveira, Jarbas
J. de Azevedo, Mirela
author2_role author
author
author
dc.contributor.author.fl_str_mv Zelmanovitz, Themis
L. Gross, Jorge
Oliveira, Jarbas
J. de Azevedo, Mirela
description OBJECTIVE: To assess the performance of urinary total protein measurements intimed 24-h urine collection and in a diurnal random urine specimen for the screeningand diagnosis of overt diabetic nephropathy.PATIENTS AND METHODS: A total of 167 diabetic patients (20 type 1 and 147 type2 diabetic patients; 78 women and 89 men), aged 20-84 years, collected 217 timed24-h urine specimens. Albumin was measured by immunoturbidimetry, total proteinby the sulfosalicylic acid technique, and creatinine by Jaffé’s method. According tothe timed 24-h urinary albumin excretion rate, samples were divided into three groups:normoalbuminuric (urinary albumin excretion rate < 20 mg/min; n = 84),microalbuminuric (urinary albumin excretion rate 20-200 mg/min; n = 78), andmacroalbuminuric (urinary albumin excretion rate > 200 mg/min; n = 55). Eight-sixpatients also collected 105 random urine specimens (normoalbuminuric, n = 47;microalbuminuric, n = 37; macroalbuminuric, n = 21), and urinary protein concentrationand urinary protein-to-creatinine ratio were measured. The receiver operatingcharacteristics curve approach was used to analyze the performance of the diagnostictests.RESULTS: Spearman’s coefficient of correlation of 24-h urinary albumin excretionrate versus 24-h urinary protein was 0.95 ( P < 0.001), and of 24-h urinary albuminexcretion rate versus urinary protein concentration and urinary protein-to-creatinineratio were 0.77 and 0.72, respectively (P < 0.001). The calculated areas (±SEM)under the receiver operating characteristics curve for the diagnosis of overt diabeticnephropathy were 0.9987 ± 0.001 for 24-h urinary protein, 0.9926 ± 0.006 for urinaryprotein concentration, and 0.9751 ± 0.014 for urinary protein-to-creatinine ratio. Inthe receiver operating characteristics curves, the first points with 100% sensivitywere 541 mg (95.7% specificity) for 24-h urinary protein, 431 mg/l (92.9% specificity)for urinary protein concentration, and 0.2 (76.2% specificity) for urinary protein-tocreatinine ratio.CONCLUSIONS: Measurements of proteinuria presented almost perfect accuracyfor the screening and diagnosis of overt diabetic nephropathy. Protein measurementin spot urine is a reliable and simple method for the screening and diagnosis of overtdiabetic nephropathy.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-25
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
A Convite dos Editores
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/124652
url https://seer.ufrgs.br/index.php/hcpa/article/view/124652
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/124652/84914
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 18 No. 2 (1998): Revista HCPA
Clinical and Biomedical Research; v. 18 n. 2 (1998): Revista HCPA
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767056768303104